First Manhattan’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,400
Closed -$14K 1817
2022
Q3
$14K Hold
6,400
﹤0.01% 1156
2022
Q2
$19K Sell
6,400
-6,000
-48% -$17.8K ﹤0.01% 1129
2022
Q1
$84K Hold
12,400
﹤0.01% 914
2021
Q4
$103K Hold
12,400
﹤0.01% 870
2021
Q3
$92K Sell
12,400
-26,000
-68% -$193K ﹤0.01% 877
2021
Q2
$261K Hold
38,400
﹤0.01% 685
2021
Q1
$394K Hold
38,400
﹤0.01% 581
2020
Q4
$268K Sell
38,400
-5,600
-13% -$39.1K ﹤0.01% 611
2020
Q3
$359K Hold
44,000
﹤0.01% 556
2020
Q2
$303K Hold
44,000
﹤0.01% 575
2020
Q1
$209K Hold
44,000
﹤0.01% 607
2019
Q4
$384K Hold
44,000
﹤0.01% 570
2019
Q3
$146K Sell
44,000
-30,000
-41% -$99.5K ﹤0.01% 745
2019
Q2
$366K Hold
74,000
﹤0.01% 591
2019
Q1
$458K Hold
74,000
﹤0.01% 575
2018
Q4
$249K Hold
74,000
﹤0.01% 652
2018
Q3
$481K Hold
74,000
﹤0.01% 583
2018
Q2
$566K Sell
74,000
-4,000
-5% -$30.6K ﹤0.01% 534
2018
Q1
$1.74M Hold
78,000
0.01% 374
2017
Q4
$994K Buy
78,000
+47,000
+152% +$599K 0.01% 448
2017
Q3
$482K Buy
+31,000
New +$482K ﹤0.01% 545